Welcome to LookChem.com Sign In|Join Free

CAS

  • or

853297-04-8

Post Buying Request

853297-04-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

853297-04-8 Usage

Description

[4-AMino-2-(trifluoroMethyl)phenyl](4-Methyl-1-piperazinyl)Metha is a complex organic molecule with a molecular formula that incorporates various functional groups, including amino, trifluoromethyl, phenyl, methyl, piperazinyl, and metha. The presence of the piperazinyl group suggests potential pharmaceutical or medicinal applications, as this group is commonly found in drugs and biologically active compounds. The trifluoromethyl and phenyl groups also indicate possible interactions with biological systems, making it a candidate for drug development or therapeutic use. Further research and experimentation are required to determine its specific pharmacological properties and potential applications.

Uses

Used in Pharmaceutical Industry:
[4-AMino-2-(trifluoroMethyl)phenyl](4-Methyl-1-piperazinyl)Metha is used as a potential pharmaceutical compound for its possible interactions with biological systems due to the presence of the piperazinyl group and other functional groups. Its specific applications and therapeutic uses would need to be determined through additional research and development.
Used in Drug Development:
[4-AMino-2-(trifluoroMethyl)phenyl](4-Methyl-1-piperazinyl)Metha is used as a candidate for drug development, given its complex molecular structure and the potential for biological activity. The trifluoromethyl and phenyl groups may contribute to its ability to target specific biological pathways or receptors, which could be harnessed for therapeutic purposes. Further studies are necessary to explore its potential as a drug candidate.

Check Digit Verification of cas no

The CAS Registry Mumber 853297-04-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,3,2,9 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 853297-04:
(8*8)+(7*5)+(6*3)+(5*2)+(4*9)+(3*7)+(2*0)+(1*4)=188
188 % 10 = 8
So 853297-04-8 is a valid CAS Registry Number.

853297-04-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name [4-amino-2-(trifluoromethyl)phenyl]-(4-methylpiperazin-1-yl)methanone

1.2 Other means of identification

Product number -
Other names [4-Amino-2-(trifluoromethyl)phenyl](4-methyl-1-piperazinyl)methanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:853297-04-8 SDS

853297-04-8Relevant articles and documents

amino animal pen amine compound can be for amplifying the synthetic method (by machine translation)

-

Paragraph 0028; 0029; 0030; 0031; 0063; 0064; 0065; 0066, (2016/10/09)

The present invention provides medical benzylamine compound containing amino novel process for the preparation of intermediates for synthesizing process. Use of relatively cheap and easy to get raw material, by a selective condensation and the reduction reaction, to obtain the relatively high yield intermediate. To the raw materials of this method, line good atom economy, simple reaction, is easy to control, after treatment is simple, high yield, and is easy to enlarge the production, less waste residues, the present invention can effectively and the production of low-cost synthetic intermediate. (by machine translation)

PROTEIN KINASE INHIBITORS (VARIANTS), USE THEREOF IN TREATING ONCOLOGICAL DISEASES AND A PHARMACEUTICAL COMPOSITION BASED THEREON

-

Page/Page column, (2014/07/07)

The present invention relates to the treatment of oncological, chronic inflammatory and similar diseases with the aid of new families of chemical compounds having improved efficiency with regard to the inhibition of Abl kinase and mutant forms thereof, as well as other therapeutically significant kinases. It describes protein kinase inhibitors in the form of compounds of general formula (I) and compounds of general formula (II), or a tautomer, an individual isomer, a mixture of isomers, a pharmaceutically acceptable salt, a solvate or a hydrate thereof.

FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF

-

Page/Page column 128-129, (2008/06/13)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 853297-04-8